ILK and neoplasm: Integrin-linked kinase (ILK), which is normally involved in regulating ECM signaling (195, 196), leads to E-cadherin suppression and promotion of tumor invasiveness (197–200) alongside a fibroblastic phenotype when aberrantly upregulated in EMT.